Clinical Trials List
2023-10-02 - 2026-12-31
Phase III
Recruiting7
ICD-10C50.911
Malignant neoplasm of unspecified site of right female breast
ICD-10C50.912
Malignant neoplasm of unspecified site of left female breast
ICD-10C50.919
Malignant neoplasm of unspecified site of unspecified female breast
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9174.9
Malignant neoplasm of female breast, unspecified
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 何蕙余 無
- Shin-Cheh Chen 無
- Wen-Chi Shen 無
- Chi-Chang Yu 無
- Chia-Hui Chu 無
- 周旭桓 無
- Chan-Keng Yang 無
- 沈士哲 無
- Mengting Peng 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Shen Liang Shih 無
- Fang-Ming Chen 無
- 巫承哲 無
- 高理鈞 無
- Chung-Liang Li 無
- Chieh-Han Chuang 無
- 甘蓉瑜 無
- 高捷妮 無
- Junping Shiau Shiau 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Shang-Hung Chen 無
- Chun-Hui Lee 無
- Jui-Hung Tsai 無
- Kuo-Ting Lee 無
- Zhu-Jun Loh 無
- 楊舜如 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- HUI-WEN LIU 無
- 蘇智銘 無
- 莊博雅 無
- Yao-Yu Hsieh 無
- 廖立民 無
- KA-WAI TAM 無
- Tsu-Yi Chao 無
- Wei-Hong Cheng 無
- TSU-YI CHAO 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
24 participants
-
Global
382 participants
